Scinai Immunotherapeutics (SCNI) Accounts Payables (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Scinai Immunotherapeutics (SCNI) has disclosed Accounts Payables for 2 consecutive years, with $407000.0 as the latest value for Q4 2025.

• Quarterly Accounts Payables rose 8.24% to $407000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $407000.0 through Dec 2025, up 8.24% year-over-year, with the annual reading at $407000.0 for FY2025, 8.24% up from the prior year.
• Accounts Payables hit $407000.0 in Q4 2025 for Scinai Immunotherapeutics, up from $376000.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $407000.0 in Q4 2025 to a low of $376000.0 in Q4 2024.

Peer Comparison